Tempus Wealth Planning’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.82M Buy
2,351
+49
+2% +$50.1K 0.55% 44
2026
Q1
$2.12M Buy
2,302
+8
+0.3% +$8.11K 0.49% 53
2025
Q4
$2.47M Sell
2,294
-97
-4% -$92.7K 0.56% 41
2025
Q3
$1.82M Sell
2,391
-24
-1% -$17.9K 0.42% 57
2025
Q2
$1.88M Sell
2,415
-476
-16% -$370K 0.47% 57
2025
Q1
$2.39M Buy
2,891
+141
+5% +$117K 0.71% 36
2024
Q4
$2.12M Buy
2,750
+356
+15% +$295K 0.65% 43
2024
Q3
$2.12M Buy
2,394
+35
+1% +$31.5K 0.78% 33
2024
Q2
$2.14M Buy
2,359
+71
+3% +$56.8K 0.89% 25
2024
Q1
$1.78M Buy
2,288
+57
+3% +$40.6K 0.78% 30
2023
Q4
$1.3M Buy
2,231
+7
+0.3% +$4.09K 0.57% 53
2023
Q3
$1.19M Buy
2,224
+15
+0.7% +$7.73K 0.6% 40
2023
Q2
$1.04M Buy
2,209
+25
+1% +$10.5K 0.47% 65
2023
Q1
$750K Sell
2,184
-8
-0.4% -$2.7K 0.37% 72
2022
Q4
$802K Hold
2,192
0.49% 63
2022
Q3
$709K Sell
2,192
-8
-0.4% -$2.54K 0.47% 60
2022
Q2
$713K Hold
2,200
0.59% 48
2022
Q1
$630K Sell
2,200
-12
-0.5% -$3.09K 0.45% 59
2021
Q4
$611K Hold
2,212
0.33% 81
2021
Q3
$511K Buy
2,212
+132
+6% +$32.6K 0.29% 88
2021
Q2
$477K Hold
2,080
0.32% 89
2021
Q1
$389K Hold
2,080
0.41% 63
2020
Q4
$351K Hold
2,080
0.45% 50
2020
Q3
$308K Sell
2,080
-10
-0.5% -$1.55K 0.45% 52
2020
Q2
$343K Hold
2,090
0.51% 45
2020
Q1
$290K Sell
2,090
-20
-0.9% -$2.75K 0.48% 46
2019
Q4
$277K Buy
+2,110
New +$245K 0.24% 65

Other funds holding LLY

Tempus Wealth Planning's LLY Position: Q2 2026 in Review

Tempus Wealth Planning increased its Eli Lilly (LLY) stake by 2.1% in Q2 2026, buying an estimated $50.1K and bringing the position to 2,351 shares worth $2.82M. The position accounts for 0.55% of the portfolio, ranked #44.

Tempus Wealth Planning first reported a position in LLY in Q4 2019 and has held it in 27 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Tempus Wealth Planning held 2,351 shares of Eli Lilly worth $2.82M as of Q2 2026.
  • Tempus Wealth Planning bought 49 Eli Lilly shares in Q2 2026, an estimated $50.1K.
  • Eli Lilly made up 0.55% of Tempus Wealth Planning's portfolio in Q2 2026, its #44 holding.
  • Tempus Wealth Planning first reported a position in Eli Lilly in Q4 2019 and has held it in 27 quarters since.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Tempus Wealth Planning's 13F filing for Q2 2026, filed 22 Jul 2026.